European Journal of Haematology

Cover image for Vol. 99 Issue S87

Edited By: Karl-Anton Kreuzer

Impact Factor: 2.653

ISI Journal Citation Reports © Ranking: 2016: 33/70 (Hematology)

Online ISSN: 1600-0609

Author Guidelines


The EUROPEAN JOURNAL OF HAEMATOLOGY (EJH) accepts the following manuscript types:

Original Articles
Manuscripts containing original research from all fields in haematology are considered for publication. It is understood that neither the article nor any of its essential parts has been or will be published elsewhere, with the exemption of presentations at scientific meetings. For organization of the manuscript see below. Manuscripts must not exceed 4,000 words excluding abstract, references, tables, figures and legends. A maximum of 50 references is allowed. A maximum of six figures or tables is allowed. Additional figures/tables must be clearly marked as supplemental and will be published as such only electronically.

Review Articles
Review articles on recent developments or history of haematology may be solicited by the Editor-in-Chief. Suggestions are welcomed in the form of a one-page synopsis. Review articles must be exhaustive and should include appropriate reference to the literature. Review articles will go through the usual peer-review process before a final decision regarding publication is made. Manuscripts must not exceed 6,000 words excluding abstract, references, tables, figures and legends. A maximum of 80 references is allowed.

Letters to the Editor
EJH welcomes critical or ancillary comments to manuscripts published in the journal. These should be addressed to the Editor-in-Chief, indicating that they are regarded as a “letter to the editor” and not as an original article. They may contain one table or figure and should not be more than 500 words. The editor reserves the right to edit the letters for clarity. A title must accompany the letter.

Case Reports
EJH accepts a very limited number of case reports. These must provide fundamental new information on a relevant topic. Sole descriptions of unusual or rare clinical cases without a clear impact for future research are not sufficient to be published in this category. Reports must be instructive and contain a critical review of the literature related to the presented case. Case reports must not exceed 1,000 words excluding abstract, references, tables, figures and legends. A maximum of 2 tables or figures and 5 references is allowed.

Clinical Pictures
As of 01.03.2015 this manuscript category will be closed and no submissions accepted.

Manuscripts should be submitted online at: For questions regarding submission, please contact the editorial office: . Re-submitted manuscripts should also be submitted in the above manner.

Original manuscripts must be divided into the following consecutive sections, each beginning on a separate page:
 Title page
 Abstract & Key Words
 Introduction
 Patients and Methods/Materials and Methods
 Results
 Discussion
 Acknowledgements (optional)
 References
 Tables (if applicable)
 Illustrations (if applicable)
 Legends (if applicable)
Review articles, letters to the editor, and case reports do not require a specific structure. The pages of the manuscript, beginning with the title page, should be numbered consecutively. All sections of the manuscript must be double-spaced. Abbreviations, symbols and nomenclature should be standardized and in accordance with Baron DN (ed) Units, Symbols and Abbreviations. The Royal Society of Medicine, 1 Wimpole Street, London W1M 8AE, 1994. Authors must make sure that their article is written in idiomatic English and that typing errors have been carefully eliminated.

For preparation of the manuscript sections please consider the following:

Title Page
The title page should contain an informative title, author(s)'s names and their affiliations. Name, address, telephone and fax numbers and e-mail address of the corresponding author. If the title exceeds 40 characters (letters and spaces) a running title of no more than 40 characters must be supplied. The following information is also required on the title:

- Abstract word count
- Manuscript word count
- Number of references
- Number of figures and tables
- Number of supplemental illustrations/tables

Abstract and Key Words
The abstract must not exceed 200 words and should be arranged in a structured fashion (to include objectives, methods, results and conclusions.) It should state the purpose of the study, basic procedures (study subject /patients/animals and methods), main findings (specific data and statistical significance), and principal conclusions. Below the abstract, provide 3-10 key words that will assist indexers in cross-indexing the article. Use terms from the Medical Subject Headings list from Index Medicus whenever possible.

Present the background briefly, but do not review the subject extensively. Give only perti-nent references. State the specific questions you want to answer.

Patients and Methods / Materials and Methods
Describe selection of patients or experimental animals, including controls. Do not use pa-tients' names or hospital numbers. Identify methods, apparatus (manufacturer's name and address), and procedures in sufficient detail to allow other workers to reproduce the results. Provide references and brief descriptions of methods that have been published. Identify drugs and chemicals, including generic name, dosage and route(s) of administration. Authors must indicate that the procedures were approved by the Ethical Committee of Human Experimentation in their country, and are in accordance with the current version of the Helsinki Declaration. All papers reporting experiments using animals must include a statement in the Material and methods section giving assurance that all animals received humane care. The authors accept full responsibility for the accuracy of the whole content, including findings, citations, quotations and references contained in the manuscript.

Information regarding clinical trials
EUROPEAN JOURNAL OF HAEMATOLOGY will only consider publishing clinical trials that have been registered in a public trials registry. The name of the registry and the registration number should be stated at the end of the abstract of the manuscript. Trials must register at or before patients are enrolled. We define clinical trials according to ICMJE, as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause and effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as pharmacokinetics or major toxicity (e.g., phase I trials), would be exempt.
Registries that currently meet the EJH criteria include:
 The registry sponsored by the U.S. National Library of Medicine (
 The International Standard Randomised Controlled Trail Number Registry (
 The National (U.K.) Research Register (
For other registries please contact the editorial office.
The Editor-in-Chief reserves the right to reject manuscripts that do not comply with the above mentioned requirements. The author will be held responsible for false statements or for failure to fulfill the above mentioned requirements.

Present results in logical sequence in tables and illustrations. In the text, explain, emphasize or summarize the most important observations. Units of measurement should be expressed in accordance with Système International d'Unite (SI Units).

Do not repeat in detail data given in the Results section. Emphasize the new and important aspects of the study. Relate the observations to other relevant studies. On the basis of your findings (and others') discuss possible implications / conclusions.

Acknowledge only persons who have made substantive contributions to the study. Authors are responsible for obtaining permission from everyone acknowledged by name because readers may infer their endorsement of the data and conclusions. Authors are expected to disclose any commercial or other relationships that could constitute a conflict of interest. Financial support should be acknowledged as a footnote on the title page. All contributors who do not qualify as authors should be mentioned under Acknowledgements. EUROPEAN JOURNAL OF HAEMATOLOGY adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). According to the ICMJE authorship criteria should be based on 1) substantial contributions to conception and design of, or acquisition of data or analysis and interpretation of data, 2) drafting the article or revising it critically for important intellectual content and 3) final approval of the version to be published. Authors should meet conditions 1, 2 and 3.

Conflict of Interest and Sources of Funding
Authors are required to disclose all sources of institutional, private and corporate financial support for their study. Suppliers of materials (for free or at a discount from current rates) should be named in the source of funding and their location (town, state/county, country) included. Other suppliers will be identified in the text. If no funding has been available other than that of the author's institution, this should be specified upon submission. Authors are also required to disclose any potential conflict of interest. These include financial interests (for example patent, ownership, stock ownership, consultancies, speaker's fee,) or provision of study materials by their manufacturer for free or at a discount from current rates. Author's conflict of interest (or information specifying the absence of conflicts of interest) and the sources of funding for the research will be published under a separate heading entitled "Conflict of Interest and Sources of Funding Statement". See ICJME website for generally accepted definitions.

Number references consecutively in the order in which they are first mentioned in the text. Identify references in text, tables and legends by Arabic numerals (in parentheses). All references cited, and only these, must be listed at the end of the paper. References should be according to the style used in Index Medicus and the International List of Periodical Title Word Abbreviations (ISO 833). All authors must be listed.
Standard journal articles
1. International Steering Committee. Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1997; 336: 309.
2. Cieutat AM, Lobel P, August JT, Kjeldsen L, Sengelov H, Borregaard N, Bainton DF. Azurophilic granules of human neutrophilic leukocytes are deficient in lysosome-associated membrane proteins but retain the mannose 6-phosphate recognition marker. Blood 1998; 91: 1044-1058.
Chapter in a book
3. Philips DJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management, 2nd ed. New York: Raven Press, 1995: 465-478.
4. Rausch C, Murgatroyd PW, Schnickelheim Z, eds. Cerebral glucose utilization testing. New York: Medical Press, 1989:141-149.

Tables should be numbered consecutively with Arabic numerals. Type each table on a separate page, and provide clear descriptive titles.

All figures should clarify the text and their numbers be kept to a minimum. Details must be large enough to retain their clarity after reduction in size. Illustrations should preferably fill a single-column width (81 mm) after reduction, although 2/3-page width (112 mm) or full-page width (168 mm) will be accepted if necessary. Magnifications should be indicated in the legends rather than by inserting scales on figures. Halftones should exhibit high contrast.
We would like to receive your artwork in electronic form. Please save vector graphics (e.g. line artwork) in Encapsulated Postscript Format (EPS), and bitmap files (e.g. halftones) in Tagged Image File Format (TIFF) at a minimum resolution of 300 dpi. Detailed information on our digital illustration guidelines is available at the Author Services website. It is the policy of EJH for authors to pay the full cost for the reproduction of their colour artwork. Therefore, please note that if there is colour artwork in your manuscript when it is accepted for publication, Wiley-Blackwell requires you to complete and return a colour work agreement form before your paper can be published. However, you may have any colour figures published in colour on the journal web site free of charge.

Kindly return the completed form to the address stated in the form.

Please note that in cases where the Editor-in-Chief deems it necessary to publish one or more illustrations in colour, acceptance for publication will be conditional on the author opting for colour reproduction of those illustrations. Any article received by John Wiley & Sons A/S with colour figures will not be published until the form has been returned.

Legends should be typed double-spaced in consecutive order on a separate page. They should be brief and specific. If micrographs are used, information about staining methods and magnification should be given.

The submission must be accompanied by a written statement, signed by the corresponding author on behalf of all authors stating that they agree to the submission, and that the material submitted is novel and not under editorial consideration in another journal. The submission of the manuscript by the authors means that they automatically agree to grant John Wiley & Sons A/S the exclusive licence to publish it if and when it is accepted for publication. The work shall not be published elsewhere in any language without the prior consent of the publisher. The articles published in this journal are protected by this licence, which covers translation rights and the exclusive right to reproduce and distribute all of the articles printed in the journal. No material published in the journal may be stored on microfilm or videocassettes or in electronic databases and the like or reproduced photographically without the prior written permission of the publisher.

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below: CTA Terms and Conditions.

For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
 Creative Commons Attribution Non-Commercial License OAA
 Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services and visit the Wiley Open Access copyright & license web page.

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit the Wiley Funder Policies website.

For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:
 Creative Commons Attribution License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services and visit the Wiley Open Access copyright & license web page.

Upon receipt an associate editor sends the manuscript to two independent reviewers with particular expertise in the field. The reviewers' reports are mailed to the associate editor who recommends on the fate of the manuscript to the Editor-in-Chief. The journal aims at having review of the manuscript completed within four weeks of receipt. The corresponding author will receive the reviewers´ comments and the editorial decision by e-mail.

EUROPEAN JOURNAL OF HAEMATOLOGY employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.



Online production tracking

Author Services enables authors to track their article - once it has been accepted- through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production so they don't need to contact the production editor to check on progress. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit Wiley Author Services for more details on online production tracking and a wealth of resources including FAQs and tips on article preparation, submission and more.

Page proofs will be despatched via email notification of a link with a downloadable Acrobat PDF file to the corresponding author. Corrections should be returned within 3 days of receipt. Alterations to the text, other than corrections, may be charged to the author.

A PDF offprint of the online published article will be provided free of charge to the corre-sponding author, and may be distributed subject to the Publisher's terms and conditions. Paper offprints of the printed published article may be purchased if ordered via the method stipulated on the instructions that accompany the proofs. Printed offprints are posted to the correspondence address given for the paper unless a different address is specified when ordered. Note that it is not uncommon for printed offprints to take up to eight weeks to arrive after publication of the journal. Electronic offprints are sent to the corresponding author at his or her corresponding email address as given on the title page of the paper, unless advised otherwise.

Complete this checklist before sending your final manuscript:
 Cover letter (optional)
 Five suggested reviewers (optional)
 Article properly formated (double-spaced) and structured
 Sections in the right order
 Title page includes required information (see above)
 Abstract does not exceed 250 words
 Permission to reproduce any previously published material and patient permission to publish photographs